SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-19-002757
Filing Date
2019-04-30
Accepted
2019-04-30 12:51:31
Documents
5
Period of Report
2019-06-19
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a_043019.htm DEF 14A 290579
2 GRAPHIC simard.jpg GRAPHIC 3772
3 GRAPHIC proxycard_1.jpg GRAPHIC 172052
4 GRAPHIC proxycard_2.jpg GRAPHIC 76129
5 GRAPHIC proxycard_3.jpg GRAPHIC 215344
  Complete submission text file 0001171843-19-002757.txt   935338
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37347 | Film No.: 19779901
SIC: 2834 Pharmaceutical Preparations